Sysmex Signs Supply and Distribution Agreement with Streck

Sysmex Inostics, a subsidiary of Sysmex Corporation, today announced that Sysmex Corporation has signed a worldwide supply and distribution agreement with Streck, Inc.

The agreement allows Sysmex to supply Streck Cell-Free DNA BCT^® and Streck Cell-Free DNA BCT^® CE blood collection tubes as part of their medical diagnostic products and services.

"Streck is recognized worldwide for its innovative direct-draw blood collection tubes. Our internal studies have shown that Streck Cell-Free DNA BCT^® blood collection tubes are ideal for stabilizing cell-free DNA to allow for efficient and effective collection and transport of specimens at ambient temperatures. As a result, we are including the Streck blood collection tubes with our products and services associated with our OncoBEAM™ assays," said Vishal Sikri, Vice President of Commercial Operations at Sysmex Inostics.

"Streck's partnership with Sysmex spans more than three decades," said Connie Ryan, President and CEO at Streck. "Our new agreement with Sysmex supports the collaboration of that long-term partnership and the expansion of our product portfolio."

Sysmex Inostics' highly sensitive molecular diagnostic testing solutions allow for molecular genetic analysis of cell-free tumor DNA from blood or plasma, delivering an individualized approach to complement treatment decision-making in oncology. Their minimal-invasive nature reveals new possibilities for cancer management, while minimizing costs and risks inherent with tissue biopsies.